ABOUT
A wholly-owned subsidiary of Paragon Biosciences, Paragon Health Capital was founded in 2019 to work closely with Paragon company management teams and boards to achieve their strategic and financial objectives. We have managed narrow and broad M&A and capital raise processes and are exclusively focused on delivering outstanding outcomes and facilitating value-generating transactions.
We assist our clients in achieving optimal outcomes through our dedication to:
-
Extensive preparation and planning to ensure companies are best positioned for success
-
Deep experience across numerous transaction types, structures and situations
-
Customized processes to achieve objectives
-
Outstanding levels of service
-
Rigorous focus on execution
​
We are frequently evaluating top-tier talent with experience in investment banking, consulting, commercial banking, corporate development, operating and/or venture capital experience. Join our team.
OUR CLIENTS
Harmony Biosciences (NASDAQ: HRMY) develops new treatment options for patients with sleep-wake disorders and other neurological conditions. In four years, Harmony received FDA approval for the first nonscheduled treatment for narcolepsy, made the therapy available to patients, went public and became profitable.
Castle Creek Biosciences is a late-stage cell and gene therapy company developing treatments for skin, connective tissue and metabolic diseases.
Founded by Paragon Biosciences, Castle Creek’s pipeline uses cutting-edge technologies that create optimal therapies for a broad range of genetic diseases.
